Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Hone

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Medical Teacher|May 10, 2018
Teaching of gynecological examinations: Medical student perspectiveOliver Carr, Luke Hone, Thomas McKane
Frontiers in Neurology|February 25, 2022
Predicting Multiple Sclerosis: Challenges and OpportunitiesLuke Hone, Gavin Giovannoni, Ruth Dobson, et al.
Journal of Neurology|May 9, 2022
Age-specific effects of childhood body mass index on multiple sclerosis riskLuke Hone, Benjamin M Jacobs, Charles Marshall, et al.
Leukemia Research|July 2, 2022
2022 update on the clinical outcome of coronavirus disease 2019 in haemato-oncology patientsSusie Bradwell, Luke Hone, Kirstie Thorneycroft, et al.
Multiple Sclerosis and Related Disorders|March 13, 2024
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorderMoneeb Nasir, Luke Hone, Emma Tallantyre, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Medical Teacher|May 10, 2018
Teaching of gynecological examinations: Medical student perspectiveOliver Carr, Luke Hone, Thomas McKane
Frontiers in Neurology|February 25, 2022
Predicting Multiple Sclerosis: Challenges and OpportunitiesLuke Hone, Gavin Giovannoni, Ruth Dobson, et al.
Journal of Neurology|May 9, 2022
Age-specific effects of childhood body mass index on multiple sclerosis riskLuke Hone, Benjamin M Jacobs, Charles Marshall, et al.
Leukemia Research|July 2, 2022
2022 update on the clinical outcome of coronavirus disease 2019 in haemato-oncology patientsSusie Bradwell, Luke Hone, Kirstie Thorneycroft, et al.
Multiple Sclerosis and Related Disorders|March 13, 2024
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorderMoneeb Nasir, Luke Hone, Emma Tallantyre, et al.
Pageof 1